EXPRS2: ExpreS2ion Biotech Holding AB (publ) - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

ExpreS2ion Biotech Holding AB (publ)

SWE:EXPRS2

SummaryFactSheetFinancial
Price
kr1.40
Loss Chance
57.9%
1.33JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Biotechnology
10 / 30
Health Care
35 / 105
Sweden
?
308 / 618
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Biovica International AB (publ)
SWE:BIOVIC B
3.66
kr0.45
100.00%
Bonesupport Holding AB (publ)
SWE:BONEX
6.92
kr219.40
320.57%
Devyser Diagnostics AB (publ)
SWE:DVYSR
4.48
kr61.80
150.38%
Medivir AB (publ)
SWE:MVIR
1.95
kr1.75
100.00%
Oncopeptides AB (publ)
SWE:ONCO
3.28
kr1.60
100.00%
Jitta Factors
Growth Opportunity (51)
Recent Business Performance (67)
Financial Strength (24)
Return to Shareholders (3)
Competitive Advantage (37)
Jitta Signs
Recent Business PerformanceEarning Growth Last Year
Cash Conversion CycleLess than 30 days
Revenue and EarningEarning loss detected in 2025
Operating MarginInconsistent
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.33
100.00%
2.37
111.17%
2.89
158.61%
Biotechnology
3.66
100.00%
6.92
320.57%
4.48
150.38%
COMPANY DESCRIPTION
ExpreS2ion Biotech Holding AB (publ), a clinical-stage biotechnology company, develops protein-based immunotherapies and vaccines for oncology and infectious diseases in the Nordics and internationally. The company’s lead asset is ES2B-C001, an immunotherapy candidate, which is in Phase 1 clinical trials for breast cancer that targets the human epidermal growth factor receptor 2, as well as vaccines for Nipah virus, Malaria, and influenza. It also offers GlycoX-S2, a glyco-engineered variants of the ExpreS2 platform to modify glycosylation patterns in expressed proteins. The company has collaboration agreement with University of Oxford for the development of vaccine for malaria. ExpreS2ion Biotech Holding AB (publ) was incorporated in 2015 is based in Helsingborg, Sweden.
expres2ionbio.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.